CLDI

Calidi Biotherapeutics INC

-$45.9K

Net Activity

Institutions Holding

28

Popularity Rank

#7464

Avg Weight

0.04%

Total Value

$478.8K

Ownership Trend

28 institutions currently hold CLDI, with 12 net buyers and 8 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

8

Net Buying Institutions

12

Key Holders

View all 28 holding institutions

Quarterly Activity

Recent Activity

+$437.4K

Total Buy Value

$234.5K

Total Sell Value

New buy5
Trim3
Add7
Sold out5

12

Net Buyers

8

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

Calidi Biotherapeutics has replaced its existing lease with a new 44-month lease for its offices and lab space, starting in October 2026. The company expects this move will save roughly $1.1 million per year in rent and facility costs. The lease includes a three-year renewal option.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CALIDI BIOTHERAPEUTICS INC (CLDI)?
Major stakeholders currently include Armistice Capital, LLC ($209.9K), Sabby Management, LLC ($103.9K), Warberg Asset Management LLC ($59.5K). Based on the latest 13F filings, there are a total of 28 tracked investment funds and institutions maintaining positions in CLDI.
What is the overall institutional sentiment toward CLDI recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $45.9K, driven by 12 managers accumulating shares while 8 reduced their exposure.
Which institutions have been selling or reducing their CLDI positions?
In the latest period, 3 funds trimmed their holdings, and 5 managers completely exited their positions. The aggregate reported sell value was $234.5K.
Are there any notable investors adding CLDI to their portfolios?
Yes, buying activity remains notable. 5 institutions opened new positions in {ticker}, and 7 existing holders added to their shares. The total reported buy value for the quarter amounted to $437.4K.

Related Stocks